Detalhe da pesquisa
1.
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
Proc Natl Acad Sci U S A
; 114(52): 13679-13684, 2017 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29229836
2.
Interleukin 32 expression in human melanoma.
J Transl Med
; 17(1): 113, 2019 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953519
3.
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
BMC Cancer
; 15: 356, 2015 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25939769
4.
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma.
Mol Cancer
; 13: 194, 2014 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25142146
5.
On your time: online training for the public health workforce.
Health Promot Pract
; 15(1 Suppl): 48S-55S, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578365
6.
MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species.
bioRxiv
; 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014031
7.
High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry.
Front Immunol
; 13: 833636, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35185925
8.
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapy.
J Clin Invest
; 131(12)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914706
9.
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma.
Mol Cancer
; 14: 128, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26134498
10.
Precise T cell recognition programs designed by transcriptionally linking multiple receptors.
Science
; 370(6520): 1099-1104, 2020 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243890
11.
PAK4 inhibition improves PD-1 blockade immunotherapy.
Nat Cancer
; 1(1): 46-58, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-34368780
12.
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.
Cancer Discov
; 10(8): 1140-1157, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467343
13.
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist.
Nat Commun
; 11(1): 660, 2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005809
14.
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
Cancer Cell
; 38(4): 500-515.e3, 2020 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32916126
15.
Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.
Nat Med
; 25(8): 1319, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31267021
16.
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.
Nat Med
; 25(6): 936-940, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171879
17.
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.
Clin Cancer Res
; 25(7): 2096-2108, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573690
18.
Immunotherapy Resistance by Inflammation-Induced Dedifferentiation.
Cancer Discov
; 8(8): 935-943, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29899062
19.
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.
Cancer Cell
; 33(5): 890-904.e5, 2018 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29657129
20.
Genetic Mechanisms of Immune Evasion in Colorectal Cancer.
Cancer Discov
; 8(6): 730-749, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29510987